By Patrick Hahn
Peter Doshi is an
Associate Professor of Pharmaceutical Health Services at the University of
Maryland, an Associate Editor at the BMJ, and a leading advocate for
clinical trial transparency.
In a 26 November editorial in the BMJ, Dr. Doshi noted that we still don’t know whether the vaccine saves lives or prevents transmission of the disease to others. Moreover, he argued that without access to the patient-level data, we don’t even really know whether the vaccine has any efficacy regarding the primary endpoint of the trial, which is Covid-19 infection of any severity.
The trial …read more
Source: blogs.naturalnews.com
Thanks! Share it with your friends!
Tweet
Share
Pin It
LinkedIn
Google+
Reddit
Tumblr